首页>
外国专利>
Treatment of adverse effects associated with administration of extracellular hemoglobin
Treatment of adverse effects associated with administration of extracellular hemoglobin
展开▼
机译:治疗与细胞外血红蛋白给药相关的不良反应
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to methods of lessening the severity and frequency of adverse effects associated with administration of extracellular hemoglobin comprising administration of a smooth muscle relaxant. Preferred smooth muscle relaxants are terbutaline and nifedipine, which can be administered in a prophylactic treatment, responsive regimented treatment or responsive intermittent treatment.
展开▼